期刊文献+

注射用酒石酸长春瑞滨胶束及注射用长春瑞滨在比格犬体内的毒动学比较

Toxicokinetics comparison between vinorelbine tartrate micelle for injection and vinorelbine tartrate for injection in beagle dogs
原文传递
导出
摘要 目的测定连续给予注射用酒石酸长春瑞滨胶束的毒动学参数,并与注射用酒石酸长春瑞滨进行比较。方法选取16只比格犬随机分为4组,雌雄各半,分别连续iv给予注射用酒石酸长春瑞滨胶束低、中、高剂量(0.29、0.58、1.174 mg/kg)与注射用酒石酸长春瑞滨1.174 mg/kg,建立测定比格犬血浆中酒石酸长春瑞滨浓度的液相色谱-串联质谱(LC-MS/MS)法,测定血药浓度,采用DAS3.1.4药动学软件计算动力学参数。结果比格犬iv给予注射用酒石酸长春瑞滨胶束低、中、高3个剂量,血药浓度、AUC(0-t)、Cmax随给药剂量的增加而增大;连续iv给药,低、中、高剂量组动物血药浓度、AUC(0-t)、Cmax在给药第1、29、71天时均变化不大,无明显蓄积倾向。而注射用长春瑞滨胶连续iv给药后随给药时间延长,动物血药浓度、AUC(0-t)、Cmax有上升趋势,AUC(0-t)蓄积因子分别为2.08、1.80,Cmax蓄积因子分别为2.58、2.32,均有蓄积倾向。结论注射用酒石酸长春瑞滨胶束与普通注射用酒石酸长春瑞滨毒动学参数比较,无明显的蓄积倾向,可降低长期服药的毒性风险。 Objective To establish a quick method to analyze vinorelbine tartrate in plasma of beagle dogs and compare the toxicokinetics of vinorelbine tartrate micelle for injection and vinorelbine tartrate for injection.Methods Sixteen beagle dogs were selected and divided into four groups,who received multiple dose of 0.29,0.58 and 1.174 mg/kg vinorelbine tartrate micelle for injection and 1.174 mg/kg vinorelbine tartrate for injection respectively.The plasma concentrations of vinorelbine tartrate micelle were determined by LC-MS/MS.Using DAS3.1.4 pharmacokinetic software to calculate the kinetic parameters.Results The blood concentration,AUC(0-t)and Cmax of beagle dogs increased with the increase of iv dose.The blood concentration,AUC(0-t)and Cmax of beagle dogs in the low,middle and high dose groups did not change significantly at the 1 st,29 th and 71 st day of administration.After iv continuous administration of vinorelbine for injection,the concentration of blood drug,AUC(0-t),Cmax increased with the increase of administration time.The accumulation factors of AUC(0-t)were 2.08,1.80,and Cmax were 2.58 and 2.32,respectively.Conclusion Compared with the pharmacokinetic parameters of vinorelbine tartrate for injection,vinorelbine tartrate for injection has no obvious accumulation tendency,which can reduce the risk of long-term toxicity.
作者 贾长虹 胡雷 肖宇萌 谷元 黄莹 JIA Changhong;HU Lei;XIAO Yumeng;GU Yuan;HUANG Ying(TIPR Drug Assessment Co.Ltd,Tianjin 300301,China)
出处 《药物评价研究》 CAS 2020年第5期866-869,共4页 Drug Evaluation Research
基金 科技部“重大新药创制”科技重大专项(2015ZX09501004-002-003)。
关键词 注射用酒石酸长春瑞滨胶束 比格犬 血浆 液相色谱-串联质谱法 毒动学 蓄积 vinorelbine tartrate micelle for injection vinorelbine tartrate for injection plasma of beagle dogs LC-MS/MS toxicokinetics accumulation
  • 相关文献

参考文献6

二级参考文献38

  • 1曹纯洁.长循环脂质体的研究进展[J].药学实践杂志,2005,23(1):1-3. 被引量:22
  • 2盛滢,孙芙蓉,于爽.静脉注射重酒石酸长春瑞滨治疗非小细胞肺癌的护理观察[J].山西医药杂志,2005,34(5):435-435. 被引量:3
  • 3秦日昇.长春瑞滨的血液毒性特点及临床意义[J].临床肿瘤学杂志,2005,10(3):312-313. 被引量:7
  • 4杨雯姝,邱利焱,金一,陈大为.RP-HPLC法测定脂质体中重酒石酸长春瑞滨的含量[J].药物分析杂志,2006,26(5):646-648. 被引量:10
  • 5Crawford J.Vinorelbine (navelbine) in non-small cell lung cancer[J].Future directions Lung Cancer,1995,12(3):311.
  • 6Poletti P,Bettini AC,Caremoli ER,et al.Liposomal-encapsulated doxorubich (Myocet(TM),D-99) and vinorelbine in previously treated metastatic breast cancer patients:a feasibility study[J].Tumori,2008,94(5):686-690.
  • 7Huebner G,Link H,Kohne CH,et al.Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adene-or undifferentiated carcinoma of unknown primary:a randomized prospective phase Ⅱ trial[J].Br J Cancer,2009,100(1):44-49.
  • 8Zhang HY,Tang X,Li HY,et al.A lipid microsphere vehicle for vinorelbine:stability,safety and pharmacokinetics[J].Intemational Journal of Pharmaceutics,2008,348(1):70-79.
  • 9Zhigaltsev Ⅳ,Maurer N,Akhong QF,et al.Liposme-encapsulated vincristins,vinblatine and vinorelbine:a comparative study of drug loading and retention[J].Journal of Controlled Release,2005,104(1):103-111.
  • 10Webb MS,Johnstone S,Morris TJ,et al.In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylbine[J].European Journal of Phannaceutics and Biopharmaceutics,2007,65(165):289-299.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部